Skip to main content
. 2022 May;10(9):519. doi: 10.21037/atm-22-1430

Figure 8.

Figure 8

SLC2A1 was correlated with immune-checkpoint-transcripts and immune-checkpoint-blocking. (A) Four of the eight immune-checkpoint-related genes were differentially expressed in the two groups, and all four genes were highly expressed in the high SLC2A1 expression group; (B) the TIDE score of the high SLC2A1 expression group was significantly higher than that of the low SLC2A1 expression group. *, P<0.05; ***, P<0.001. TIDE, tumor immune dysfunction and exclusion.